FT : SEC targets fuel company in bailout aid investigation

SEC targets fuel company in bailout aid investigation
Connecticut-based FuelCell Energy discloses request for information over PPP loan

The US Securities and Exchange Commission is investigating a fuel cell company over its use of government rescue funds, according to the first public company disclosure of such a probe, which comes amid growing regulatory interest in the recipients of government bailouts.

FuelCell Energy, a maker of electricity generators, said the SEC’s enforcement division asked for information last month about the company’s application for a loan from the Paycheck Protection Program. FuelCell said in April that it had taken a $6.5m loan.

The PPP, a $650bn fund for keeping small businesses afloat during the economic shutdown because of the coronavirus outbreak, offered companies up to $10m or more to help with payroll costs. The funds can be written off in a couple of months if companies can prove they spent it on allowable expenses such as pay and rent.

In general, companies needed to certify they cannot obtain credit elsewhere to apply for a PPP loan.

Connecticut-based FuelCell said the SEC’s information request was voluntary and that the company intends to co-operate. The disclosure came in a previously unreported regulatory filing on June 12.

Also in the filing, the lossmaking company reported its revenues increased 105 per cent in the three months to April 30. The company said on June 16 that it was planning to sell up to $75m of new shares.

The SEC and FuelCell declined to comment.

The PPP was created in March under federal stimulus legislation known as the Cares Act and advertised as a lifeline for small businesses. Some public companies that initially took PPP loans returned them after an outcry. Shake Shack and Ruth’s Chris Steak House returned loans of $10m and $20m respectively in April.

The SEC has launched investigations into disclosures made by public companies that took PPP loans, attorneys representing the businesses said without disclosing their clients. Claimed financial hardship in the PPP application may contrast with the most recent quarterly filings with the SEC, the attorneys said.

“The SEC [staff] are scratching their heads: ‘We see you are the epitome of financial health in your SEC filings, how did you qualify and why are you taking money from the Cares Act?’” said Tom Sporkin, a former SEC enforcement official now at the law firm Buckley LLP in Washington. “My belief is that this is an industry sweep.”

The US Department of Justice has also taken an interest in the use of PPP funds and announced charges in recent weeks against people who have allegedly filed fraudulent bank loan applications under the programme.

The PPP investigations come as lawmakers are increasingly calling for information about which companies received loans under the programme. Treasury secretary Steven Mnuchin said this week he would work with Congress on PPP loan oversight. Congressional Democrats have pushed for information about which businesses have received loans.

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:

  • AMSWA -10.3%, SWBI -2.8%

Other news:

  • BYSI -18.7% (prices offering of 1,930,000 ordinary shares at $13.00 per share)
  • KRMD -15.9% (prices offering of 3,125,000 shares of its common stock at $8.00/share)
  • IDN -7.4% (stock offering)
  • VTR -3.4% (lowers quarterly dividend to $0.45 per share from $0.7925 per share; posts updated investor presentation outlining recent business trends)
  • NH -2.9% (presents clinical data)
  • VXX -2% (trading lower with futures up in pre-mkt)
  • EB -1.6% (stock offering)

Analyst comments:

  • WORK -1.5% (downgraded to Sell from Neutral at Goldman)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:

  • KMX +3.2%, HOME +0.8% 

Other news:

  • TLSA +17.7% (receives first-ever patent on a transformational technology for oral delivery of all anti-CD3 monoclonal antibodies)
  • AMC +10.1% (to resume theatre operations on Wednesday, July 15)
  • MPC +8.2% (WSJ report that co is in discussions with buyers for its Speedway unit)
  • TWO +7.1% (raises dividend)
  • DVAX +5.2% (initiates Phase 1 clinical trial for COVID-19 vaccine candidate)
  • CHMI +5% (lowers dividend)
  • CLCT +4.7% (Alta Fox to nominate slate of six highly qualified director candidates for election at Collectors Universe's 2020 annual meeting)
  • CLR +4% (provides update on voluntary production curtailments)
  • PENN +3.6% (has resumed operations at more than 70% of the company's 41 properties)
  • EVA +2.2% (increases distribution guidance for 2020)
  • SNY +2.2% (Sanofi and Regeneron (REGN) announce that Dupixent was approved in China for adults with moderate-to-severe atopic dermatitis)
  • DDOG +2.1% (announces FedRAMP authorization for low-impact SaaS)
  • CRY +1.9% (prices $100 mln 4.250% convertible senior notes due 2025 - estimates that it will receive ~$96.5 mln in net proceeds)
  • ASMB +1.5% (regains rights to all microbiome gastrointestinal programs as AbbVie terminates agreement)
  • BGNE +1.5% (reports China National Medical Products Administration has accepted a supplemental new drug application of its anti-PD-1 antibody tislelizumab in combination with chemotherapy)

Analyst comments:

  • RYAM +12.2% (upgraded to Buy from Underperform at BofA/Merrill)
  • DT +6.3% (upgraded to Buy from Neutral at Goldman)
  • OXY +6% (upgraded to Buy from Hold at SunTrust)
  • ULTA +3.2% (upgraded to Overweight from Equal Weight at Barclays)
  • SPOT +3.2% (target raised to Street-high $275 at Rosenblatt)
  • AAPL +0.9% (target raised to $405 from $370 at Jefferies on 5G cycle confidence)

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • TLSA +16.1%, DVAX +9.1%, AMC +6.9%, MPC +5.7%, CHMI +5%, CLCT +4.7%, NH +4.4%, CLR +2.8%, EVA +2.2%, DDOG +2.1%, ASMB +1.9%
  • Gapping down:
    • BYSI -22%, KRMD -15.4%, IDN -7.9%, AMSWA -5.2%, HOME -1.7%, EB -1.6%, VXX -1.3%

>>> Europe : Brokers Upgrades & Downgrades - 19th of June 2020 V2(+)

>>> Up
* Asos Price Target Raised to Street-High at Peel Hunt (+)
* Deutsche Post Raised to Neutral at Credit Suisse (+)
* LNA Sante Raised to Buy at Oddo BHF; PT 52.50 euros (+)
* Sobi Raised to Equal-Weight at Barclays; PT 205 kronor
* Swedbank Raised to Overweight at JPMorgan; PT 160 kronor
* Unicaja Raised to Buy at Grupo Santander; PT 80 euro cents
* Vopak Raised to Buy at ABN Amro Bank; PT 58 euros
* Swiss Re Raised to Neutral at Mediobanca SpA (+)
* William Hill Raised to Overweight at JPMorgan; PT 200 pence

>>> Down
* Amadeus Cut to Hold at Mirabaud Securities; PT 53.10 euros (+)
* Cancom Cut to Hold at MainFirst; PT 56 euros
* Colruyt Cut to Sell at ABN Amro Bank; PT 48 euros
* DiaSorin Cut to Sell at Kempen & Co; PT 127 euros (+)
* Domino's Pizza Group Cut to Sell at Berenberg; PT 250 pence
* Wirecard Cut to Reduce at Oddo BHF; PT 35 euros (+)

>>> Initiation
* Avast Rated New Buy at Goldman; PT 600 pence
* Flutter Reinstated Buy at Goldman; PT 13,200 pence
* Geberit Rated New Underweight at Morgan Stanley
* Inchcape Rated New Add at Peel Hunt; PT 600 pence
* PRS REIT Rated New Buy at Jefferies; PT 91 pence

>>> Call
* Amadeus Cut at Mirabaud After Rally With More Visibility Needed (+)
* Domino’s Cut to Sell as Competition Gets More Intense: Berenberg
* RBC Slashes European Airport Estimates With Data Not Encouraging
* Plenty of ESG Contenders in U.K. Construction, Jefferies Says
* Greggs Execution Tricky Amid Social Distancing, Peel Hunt Says
* Stadler Rail’s New Orders Show Demand Is Holding Up Well: Citi (+)